Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Clements

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
The Journal of Experimental Medicine|January 14, 2009
Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognitionJulia K Archbold, Whitney A Macdonald, Stephanie Gras, et al.
Immunity|December 18, 2007
The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognitionLucy C Sullivan, Craig S Clements, Travis Beddoe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognitionAlex Theodossis, Carole Guillonneau, Andrew Welland, et al.
The Journal of Biological Chemistry|January 2, 2019
A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonistsRahul Patil, Biswaranjan Mohanty, Bonan Liu, et al.
The Lancet. Respiratory Medicine|June 6, 2022
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trialStephen M Stick, Alexia Foti, Robert S Ware, et al.
Nature Immunology|September 28, 2005
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptideFleur E Tynan, Scott R Burrows, Ashley M Buckle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptabilityScott R Burrows, Zhenjun Chen, Julia K Archbold, et al.
Nature|December 3, 2025
A place-based assessment of biodiversity intactness in sub-Saharan AfricaHayley S Clements, Reinette Biggs, Alta De Vos, et al.
The Journal of Experimental Medicine|August 27, 2003
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognitionWhitney A Macdonald, Anthony W Purcell, Nicole A Mifsud, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
The Journal of Experimental Medicine|January 14, 2009
Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognitionJulia K Archbold, Whitney A Macdonald, Stephanie Gras, et al.
Immunity|December 18, 2007
The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognitionLucy C Sullivan, Craig S Clements, Travis Beddoe, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognitionAlex Theodossis, Carole Guillonneau, Andrew Welland, et al.
The Journal of Biological Chemistry|January 2, 2019
A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonistsRahul Patil, Biswaranjan Mohanty, Bonan Liu, et al.
The Lancet. Respiratory Medicine|June 6, 2022
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trialStephen M Stick, Alexia Foti, Robert S Ware, et al.
Nature Immunology|September 28, 2005
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptideFleur E Tynan, Scott R Burrows, Ashley M Buckle, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2010
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptabilityScott R Burrows, Zhenjun Chen, Julia K Archbold, et al.
Nature|December 3, 2025
A place-based assessment of biodiversity intactness in sub-Saharan AfricaHayley S Clements, Reinette Biggs, Alta De Vos, et al.
The Journal of Experimental Medicine|August 27, 2003
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognitionWhitney A Macdonald, Anthony W Purcell, Nicole A Mifsud, et al.
Pageof 29